In addition, the authors demonstrated that cyclin dependent kinase regulatory subunit 2 (CKS2) in the cell cycle dependent protein kinase subunit family, as a novel tumor biomarker, is highly expressed in HCC and that its elevated expression is predictive of poorer prognosis and tumor progression (Zhang et al., 2019). Here, CKS2 is linked to neoplasm.